The drugs industry is an enormous multibillion businesses encompassing an immense number of companies involved in the design, production and marketing of drugs worldwide. According to the type of drugs the market can be dived into the following segments: diabetes, antifungal, antidepressant, antithrombotic, hepatitis drugs, analgesics and a far more.
Currently, the drugs market is undergoing a recovery phase in the wake of the recent decline provoked by the economic slump. The market growth is spurred by increasing demand for drugs across the globe, rising incidence of chronic as well as infectious diseases, population ageing, product innovations and constant technological advancements. North America and Europe are the most prominent regional markets. Bristol-Myers Squibb, Pharmacia, GlaxoSmithKline, Merck & Co, Novartis, Eli Lilly, Pfizer, Johnson & Johnson, Allergan, Schering-Plough, Bayer and Abbott Labs are amid global drugs arena giants.
A huge collection of the research reports covering the drugs market at different geographies can be found under this MarketPublishers’ catalogue. The researches provide comprehensive assessment of the market, characterize major market trends and disclose essential market indicators. The reports describe the competitive scenario and indicate top market players. In addition, future prospects for the drugs market are thoroughly studied in the research reports.
Publications found:
9,295
Sort by:
Antinauseants Market - 2023-2031
US$ 2,999.00
The Antinauseants Market was valued at US$ 2.3 billion in 2023 and is anticipated to reach US$ 3.7 billion by 2031, at a CAGR of 0.062 from 2026 to 2032. The report delivers in-depth insights into key...
November 2025
207 pages
Antispasmodics Drug Market 2026
US$ 2,999.00
The Antispasmodics Drug Market was valued at in and is anticipated to reach by , at a CAGR of xx% from 2026 to 2032. The report delivers in-depth insights into key market dynamics, including regional...
November 2025
200 pages
Antivenom Market 2026
US$ 2,999.00
The Antivenom Market was valued at in and is anticipated to reach by , at a CAGR of 0.065 from 2026 to 2032. The report delivers in-depth insights into key market dynamics, including regional growth t...
November 2025
217 pages
Antiviral Drugs Market 2026
US$ 2,999.00
The Antiviral Drugs Market was valued at in and is anticipated to reach by , at a CAGR of xx% from 2026 to 2032. The report delivers in-depth insights into key market dynamics, including regional grow...
November 2025
218 pages
Aplastic Anemia Market 2026
US$ 2,999.00
The Aplastic Anemia Market was valued at in and is anticipated to reach by , at a CAGR of xx% from 2026 to 2032. The report delivers in-depth insights into key market dynamics, including regional grow...
November 2025
219 pages
Appendicitis Diagnostics and Treatment Market 2026
US$ 2,999.00
The Appendicitis Diagnostics and Treatment Market was valued at in and is anticipated to reach by , at a CAGR of xx% from 2026 to 2032. The report delivers in-depth insights into key market dynamics,...
November 2025
243 pages
Artemisinin Combination Therapy Market - 2023-2031
US$ 2,999.00
The Artemisinin Combination Therapy Market was valued at US$ 547 million in 2023 and is anticipated to reach US$ 1,061 million by 2031, at a CAGR of 0.088 from 2026 to 2032. The report delivers in-dep...
November 2025
218 pages
Asia Pacific Liver Disease Treatment Market - 2023-2031
US$ 2,999.00
The Asia Pacific Liver Disease Treatment Market was valued at US$ 3.84 billion in 2023 and is anticipated to reach US$ 5.83 billion by 2031, at a CAGR of 0.055 from 2026 to 2032. The report delivers i...
November 2025
220 pages
Atracurium Market 2026
US$ 2,999.00
The Atracurium Market was valued at in and is anticipated to reach by , at a CAGR of xx% from 2026 to 2032. The report delivers in-depth insights into key market dynamics, including regional growth tr...
November 2025
217 pages
Autoimmune Hemolytic Anemia Therapeutics Market 2026
US$ 2,999.00
The Autoimmune Hemolytic Anemia Therapeutics Market was valued at in and is anticipated to reach by , at a CAGR of xx% from 2026 to 2032. The report delivers in-depth insights into key market dynamics...
November 2025
223 pages
Beri Beri Treatment Market 2026
US$ 2,999.00
The Beri Beri Treatment Market was valued at in and is anticipated to reach by , at a CAGR of 0.07 from 2026 to 2032. The report delivers in-depth insights into key market dynamics, including regional...
November 2025
200 pages
Beta Thalassemia Market - 2023-2031
US$ 2,999.00
The Beta Thalassemia Market was valued at US$ 480.32 million in 2023 and is anticipated to reach US$ 889.04 million by 2031, at a CAGR of 0.081 from 2026 to 2032. The report delivers in-depth insights...
November 2025
207 pages
Bleeding Disorders Treatment Market - 2022
US$ 2,999.00
The Bleeding Disorders Treatment Market was valued at US$ 5.9 billion in 2022 and is anticipated to reach by , at a CAGR of 0.084 from 2026 to 2032. The report delivers in-depth insights into key mark...
November 2025
207 pages
Carcinoid Syndrome Diarrhea Treatment Market - 2022
US$ 2,999.00
The Carcinoid Syndrome Diarrhea Treatment Market was valued at US$ 3,514.3 million in 2022 and is anticipated to reach by , at a CAGR of 0.098 from 2026 to 2032. The report delivers in-depth insights...
November 2025
207 pages
Castleman Disease Treatment Market 2026
US$ 2,999.00
The Castleman Disease Treatment Market was valued at in and is anticipated to reach by , at a CAGR of xx% from 2026 to 2032. The report delivers in-depth insights into key market dynamics, including r...
November 2025
243 pages
Celiac Disease Drugs Market 2026
US$ 2,999.00
The Celiac Disease Drugs Market was valued at in and is anticipated to reach by , at a CAGR of 0.0828 from 2026 to 2032. The report delivers in-depth insights into key market dynamics, including regio...
November 2025
218 pages
Cholecystitis Treatment Market 2026
US$ 2,999.00
The Cholecystitis Treatment Market was valued at in and is anticipated to reach by , at a CAGR of xx% from 2026 to 2032. The report delivers in-depth insights into key market dynamics, including regio...
November 2025
207 pages
Chronic fatigue syndrome Market 2026
US$ 2,999.00
The Chronic fatigue syndrome Market was valued at in and is anticipated to reach by , at a CAGR of xx% from 2026 to 2032. The report delivers in-depth insights into key market dynamics, including regi...
November 2025
243 pages
Chronic Kidney Disease Drugs Market - 2021-2031
US$ 2,999.00
The Chronic Kidney Disease Drugs Market was valued at US$ 10,923.29 million in 2021 and is anticipated to reach US$ 19,427.41 million by 2031, at a CAGR of 0.066 from 2026 to 2032. The report delivers...
November 2025
200 pages
Cri-du-chat Syndrome Market 20262031
US$ 2,999.00
The Cri-du-chat Syndrome Market was valued at in and is anticipated to reach by 2031, at a CAGR of xx% from 2026 to 2032. The report delivers in-depth insights into key market dynamics, including regi...
November 2025
200 pages
Diamond–Blackfan Anemia (DBA) Treatment Market 2026
US$ 2,999.00
The Diamond–Blackfan Anemia (DBA) Treatment Market was valued at in and is anticipated to reach by , at a CAGR of xx% from 2026 to 2032. The report delivers in-depth insights into key market dynamics,...
November 2025
219 pages
Diverticulitis Disease Treatment Market 2026
US$ 2,999.00
The Diverticulitis Disease Treatment Market was valued at in and is anticipated to reach by , at a CAGR of 0.077 from 2026 to 2032. The report delivers in-depth insights into key market dynamics, incl...
November 2025
200 pages
Dronabinol Market 2026
US$ 2,999.00
The Dronabinol Market was valued at in and is anticipated to reach by , at a CAGR of xx% from 2026 to 2032. The report delivers in-depth insights into key market dynamics, including regional growth tr...
November 2025
200 pages
Dyspepsia Drug Market 2026
US$ 2,999.00
The Dyspepsia Drug Market was valued at in and is anticipated to reach by , at a CAGR of xx% from 2026 to 2032. The report delivers in-depth insights into key market dynamics, including regional growt...
November 2025
243 pages
Emtricitabine and Tenofovir Market 2026
US$ 2,999.00
The Emtricitabine and Tenofovir Market was valued at in and is anticipated to reach by , at a CAGR of 0.05 from 2026 to 2032. The report delivers in-depth insights into key market dynamics, including...
November 2025
207 pages
Erectile Dysfunction Drugs Market - 2023-2031
US$ 2,999.00
The Erectile Dysfunction Drugs Market was valued at US$ 3.5 billion in 2023 and is anticipated to reach US$ 5.0 billion by 2031, at a CAGR of 0.047 from 2026 to 2032. The report delivers in-depth insi...
November 2025
210 pages
Esomeprazole Market 2026
US$ 2,999.00
The Esomeprazole Market was valued at in and is anticipated to reach by , at a CAGR of xx% from 2026 to 2032. The report delivers in-depth insights into key market dynamics, including regional growth...
November 2025
220 pages
Exocrine Pancreatic Insufficiency Market 2026
US$ 2,999.00
The Exocrine Pancreatic Insufficiency Market was valued at in and is anticipated to reach by , at a CAGR of 0.065 from 2026 to 2032. The report delivers in-depth insights into key market dynamics, inc...
November 2025
207 pages
Fabry Disease Treatment Market - 2022
US$ 2,999.00
The Fabry Disease Treatment Market was valued at USD 1,876.7 million in 2022 and is anticipated to reach by , at a CAGR of 0.074 from 2026 to 2032. The report delivers in-depth insights into key marke...
November 2025
218 pages
Familial Lipoprotein Lipase Deficiency Market 2026
US$ 2,999.00
The Familial Lipoprotein Lipase Deficiency Market was valued at in and is anticipated to reach by , at a CAGR of xx% from 2026 to 2032. The report delivers in-depth insights into key market dynamics,...
November 2025
219 pages
Fatty Acid Oxidation Disorder Drugs Market 2026
US$ 2,999.00
The Fatty Acid Oxidation Disorder Drugs Market was valued at in and is anticipated to reach by , at a CAGR of xx% from 2026 to 2032. The report delivers in-depth insights into key market dynamics, inc...
November 2025
243 pages
Fecal Incontinence Therapeutics Market 2026
US$ 2,999.00
The Fecal Incontinence Therapeutics Market was valued at in and is anticipated to reach by , at a CAGR of 0.035 from 2026 to 2032. The report delivers in-depth insights into key market dynamics, inclu...
November 2025
220 pages
Focal Segmental Glomerulosclerosis Market 2026
US$ 2,999.00
The Focal Segmental Glomerulosclerosis Market was valued at in and is anticipated to reach by , at a CAGR of 0.075 from 2026 to 2032. The report delivers in-depth insights into key market dynamics, in...
November 2025
218 pages
Folinic Acid Market 2026
US$ 2,999.00
The Folinic Acid Market was valued at in and is anticipated to reach by , at a CAGR of 0.04 from 2026 to 2032. The report delivers in-depth insights into key market dynamics, including regional growth...
November 2025
243 pages
Fragile X Syndrome (Fxs) Treatment Market 2026
US$ 2,999.00
The Fragile X Syndrome (Fxs) Treatment Market was valued at in and is anticipated to reach by , at a CAGR of 0.068 from 2026 to 2032. The report delivers in-depth insights into key market dynamics, in...
November 2025
200 pages
G7 Spinocerebellar Ataxia Market - 2023-2031
US$ 2,999.00
The G7 Spinocerebellar Ataxia Market was valued at US$ 237.6 million in 2023 and is anticipated to reach US$ 385.1 million by 2031, at a CAGR of 0.063 from 2026 to 2032. The report delivers in-depth i...
November 2025
210 pages
Gallbladder Treatment Market 2026
US$ 2,999.00
The Gallbladder Treatment Market was valued at in and is anticipated to reach by , at a CAGR of 0.062 from 2026 to 2032. The report delivers in-depth insights into key market dynamics, including regio...
November 2025
243 pages
Gastrointestinal Therapeutics Market 2026
US$ 2,999.00
The Gastrointestinal Therapeutics Market was valued at in and is anticipated to reach by , at a CAGR of 0.0642 from 2026 to 2032. The report delivers in-depth insights into key market dynamics, includ...
November 2025
223 pages
Gastroparesis Drugs Market - 2023-2031
US$ 2,999.00
The Gastroparesis Drugs Market was valued at US$ 7.50 billion in 2023 and is anticipated to reach US$ 10.96 billion by 2031, at a CAGR of 0.049 from 2026 to 2032. The report delivers in-depth insights...
November 2025
243 pages
General Anesthesia Drugs Market 2026
US$ 2,999.00
The General Anesthesia Drugs Market was valued at in and is anticipated to reach by , at a CAGR of 0.0384 from 2026 to 2032. The report delivers in-depth insights into key market dynamics, including r...
November 2025
207 pages
Generalized Pustular Psoriasis Market 2026
US$ 2,999.00
The Generalized Pustular Psoriasis Market was valued at in and is anticipated to reach by , at a CAGR of xx% from 2026 to 2032. The report delivers in-depth insights into key market dynamics, includin...
November 2025
218 pages
Genitourinary Drugs Market - 2023-2031
US$ 2,999.00
The Genitourinary Drugs Market was valued at US$ 31,220.0 million in 2023 and is anticipated to reach US$ 35,518.8 million by 2031, at a CAGR of 0.016 from 2026 to 2032. The report delivers in-depth i...
November 2025
219 pages
Glomerulonephritis Treatment Market 2026
US$ 2,999.00
The Glomerulonephritis Treatment Market was valued at in and is anticipated to reach by , at a CAGR of 0.054 from 2026 to 2032. The report delivers in-depth insights into key market dynamics, includin...
November 2025
220 pages
Graft Versus Host Disease Treatment Market 2026
US$ 2,999.00
The Graft Versus Host Disease Treatment Market was valued at in and is anticipated to reach by , at a CAGR of xx% from 2026 to 2032. The report delivers in-depth insights into key market dynamics, inc...
November 2025
207 pages
Guillain-Barre Syndrome Treatment Market 2026
US$ 2,999.00
The Guillain-Barre Syndrome Treatment Market was valued at in and is anticipated to reach by , at a CAGR of 0.05 from 2026 to 2032. The report delivers in-depth insights into key market dynamics, incl...
November 2025
223 pages
Gunshot Injuries Market 2026
US$ 2,999.00
The Gunshot Injuries Market was valued at in and is anticipated to reach by , at a CAGR of xx% from 2026 to 2032. The report delivers in-depth insights into key market dynamics, including regional gro...
November 2025
223 pages
HELLP Syndrome Market 2026
US$ 2,999.00
The HELLP Syndrome Market was valued at in and is anticipated to reach by , at a CAGR of xx% from 2026 to 2032. The report delivers in-depth insights into key market dynamics, including regional growt...
November 2025
220 pages
Hematuria Treatment Market 2026
US$ 2,999.00
The Hematuria Treatment Market was valued at in and is anticipated to reach by , at a CAGR of 0.028 from 2026 to 2032. The report delivers in-depth insights into key market dynamics, including regiona...
November 2025
207 pages
